Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Prospective, Open Clinical Study of Palbociclib for Backline Treatment of Advanced Hepatocellular Carcinoma

NCT06478927 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT06478927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06478927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Prospective, Open Clinical Study of Palbociclib for Backline Treatment of Advanced Hepatocellular Carcinoma
Lead sponsor
Henan Cancer Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 15, 2024
Completion date
January 15, 2027
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma